Clinical Trial: A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07684287) titled 'A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma' on June 29.

Brief Summary: A Single-Arm, Non-Randomized, Open-Label Phase 2 Study of Nab-Sirolimus in Patients with Progressive or Symptomatic Epithelioid Hemangioendothelioma.

Detailed Description: Avoid duplicating information that will be entered or uploaded elsewhere in the record.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Epithelioid Hemangioendothelioma

Intervention: DRUG: Sirolimus for injection (Albumin-bound)

Sirolimus for injection (Albumin-bound) will be admi...